This page is for Health Care Professionals only
Galapagos is proud to be a sponsor of ECCO'23, the biggest event in the inflammatory bowel disease (IBD) calendar!
The ECCO’23 scientific programme includes a wide range of sessions presented by some of the world’s leading specialists in IBD, exploring basic science, conventional medicine, clinical practice and a wealth of intriguing, new data.
Galapagos is excited to be delivering an interactive live symposium, as well as a range of other activities throughout the congress. Don’t miss out – join us as we navigate the path to comprehensive disease control in ulcerative colitis (UC)!
Join our internationally renowned panel as they discuss these topics and share their experiences from the clinic. You will also have the chance to guide the discussion during our live Q&A session. Plus, be sure to catch our experts taking turns in the hot seat! They’ll be answering quick-fire, highly topical questions that clinicians face every day in their practice
This programme is not affiliated with ECCO
Join Professor Stefan Schreiber and Professor Marieke Pierik for the Galapagos-sponsored product theatre session at the 18th Congress of ECCO:
• Want to discover how we could do more for our patients with UC?
• Interested in an expert discussion about a comprehensive approach to UC care in clinical practice?
• Want to explore how JAK inhibition can contribute towards comprehensive disease control in UC?
Join our session on 3 March 2023, 15:00–15:20 CET
GALAPAGOS en het GALAPAGOS-logo zijn geregistreerde of aangevraagde handelsmerken van Galapagos NV.
© 2022 Galapagos NV. Alle rechten voorbehouden.
NL-UC-GLPG-202302-00004
Andere categorieën
© Copyright 2020 Galapagos NV
Vul onderstaand uw gegevens in indien u zich wilt inschrijven voor dit event.
We have sent an email to the following email address: ${userEmail}
Simply follow the password to activate your account
U staat op het punt de Galapagoshealth.nl te verlaten en wordt doorgestuurd naar een externe website. De informatie die u op de externe bestemmingssite kunt raadplegen, voldoet mogelijk niet aan de wettelijke vereisten van Nederland. Door verder te gaan, bevestigt u hiervan kennis te hebben genomen.